WHYS IN PHARMACY: COMPILATION OF REASONS UNDERLYING PHARMACY PRINCIPLES, WITH TABLE OF EQUATIONS
CONTENTS 1 CHALCONE (1,3-DIPHENYL-2-PROPENE-1-ONE) SCAFFOLD BEARING NATURAL COMPOUNDS AS NITRIC OXIDE INHIBITORS: PROMISING ANTIEDEMA AGENTS 2 EMBLICANIN-A AND EMBLICANIN-B: PHARMACOLOGICAL AND NANO-PHARMACOTHERAPEUTIC PERSPECTIVE FOR HEALTHCARE APPLICATIONS 3 RECENT IN-DEPTH INSIGHTS OF NATURE-BASED ANTI-WORM THERAPEUTIC MEDICATIONS: EMERGING HERBAL ANTHELMINTICS 4 INSIGHTS INTO THE RECENT SCIENTIFIC EVIDENCES OF NATURAL THERAPEUTIC TREASURES AS DIURETIC AGENTS 5 REVIEWING THE AVAILABLE HERBAL RESOURCES FOR TREATING PSORIASIS: SAFE AND ALTERNATIVE WAY FOR THERAPEUTICS 6 NUTRACEUTICALS AND BRAIN DISORDERS 7 1,3-DIPHENYL-2-PROPENE-1-ONE-BASED NATURAL PRODUCT ANTIDIABETIC MOLECULES AS INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE-1B (PTP-1B) 8 RE-HIGHLIGHTING THE POTENTIAL NATURAL RESOURCES FOR TREATING OR MANAGING THE AILMENTS OF GASTROINTESTINAL TRACT ORIGIN 9 RECENT ADVANCEMENTS OF CURCUMIN ANALOGS AND CURCUMIN FORMULATIONS IN CONTEXT TO MODERN PHARMACOTHERAPEUTICS PERSPECTIVES 10 EMERGING HIGHLIGHTS ON NATURAL PRODRUG MOLECULES WITH MULTIFARIOUS THERAPEUTIC PERSPECTIVES 11 PERSPECTIVES OF NATURE-ORIENTED PHARMACOTHERAPEUTICS FOR THE EFFECTUAL MANAGEMENT OF HEMORRHOIDAL SYMPTOMS 12 EFFECT OF LIGHT ON TRANSPORT OF POTASSIUM THIOCYANATE IN AQUEOUS SOLUTIONS 13 DRUG DISCOVERY, DRUG-LIKENESS SCREENING, AND BIOAVAILABILITY: DEVELOPMENT OF DRUG-LIKENESS RULE FOR NATURAL PRODUCTS 14 BIOMOLECULAR AND MOLECULAR DOCKING: A MODERN TOOL IN DRUG DISCOVERY AND VIRTUAL SCREENING OF NATURAL PRODUCTS